Two studies by Eugonia were presented at the annual meeting of ESHRE 2015
Two randomized controlled trials (RCT) by Eugonia were presented at the Annual Meeting of ESHRE 2015, which took place in Lisbon on 14-17 June 2015. This is one of the largest conferences in Assisted Reproduction, and as a result only studies of high originality and importance are accepted for presentation.
This proves that Eugonia remains at the cutting edge of clinical research. The findings of our research are quickly transferred in the treatment of our patients and are translated into the high pregnancy rates that we constantly maintain year after year.
The 2 studies include: one dose-finding clinical study on the novel method for triggering final oocyte maturation unsing GnRH agonist in women at high risk for developing ovarian hyperstimulation syndrome (OHSS).
- The optimal dose of triptorelin for triggering final oocyte maturation in patients at high-risk for OHSS: a randomized clinical trial.
Oral presentation by George Lainas.
And one embryology study comparing the effect of two different culture systems on embryo development and pregnancy rates.
- Similar implantation and pregnancy rates using a single medium versus sequential media for embryo culture: a randomized controlled trial.
Poster presentation by Ioannis Sfontouris